Sign up to save your podcasts
Or
Share #20 Colin Meyer, MD: Building a Multi-Billion Dollar Biotech Company, Connecting with Mentors, and Racing Sportscars
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
#20 Colin Meyer, MD: Building a Multi-Billion Dollar Biotech Company, Connecting with Mentors, and Racing Sportscars
Colin is Chief Medical Officer of Reata Pharmaceuticals (a public biotech company: RETA). At Reata, he leads product development and strategy, clinical trial design and analysis, and medical affairs. He joined Reata in 2003 as one of its first few employees. Colin received a B.S. in chemistry with specialization in biochemistry and a B.A. in biology from the University of Virginia. He received an M.D. from the University of Texas Southwestern Medical School and an M.B.A. from Southern Methodist University Cox School of Business.
View all episodes
By Yasanka ChalasaniColin is Chief Medical Officer of Reata Pharmaceuticals (a public biotech company: RETA). At Reata, he leads product development and strategy, clinical trial design and analysis, and medical affairs. He joined Reata in 2003 as one of its first few employees. Colin received a B.S. in chemistry with specialization in biochemistry and a B.A. in biology from the University of Virginia. He received an M.D. from the University of Texas Southwestern Medical School and an M.B.A. from Southern Methodist University Cox School of Business.